Change of Director's Interest Notice
Released
Released
Announcement PDF
Appendix 3Y
Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.
Introduced 30/9/2001.
Name of entity
PharmAust Limited
ABN
35 094 006 023
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the
director for the purposes of section 205G of the Corporations Act.
Name of Director
Dr Wayne Best
Date of last notice
24 November 2014
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed
in this part.
Direct or indirect interest
Direct & Indirect
Nature of indirect interest
(including registered holder)
Securities are held by Dr Wayne Morris
Best & Mrs Debra Jayne Best
Note: Provide details of the circumstances giving rise to the relevant
interest.
Securities are held by Mrs Debra Jayne
Best (spouse).
Date of change
21 October 2015
No. of securities held prior to change
2,874,290 Ordinary Fully Paid Shares
Class
Ordinary Fully Paid Shares
Number acquired
1,000,000 Ordinary Fully Paid Shares
Number disposed
Nil
Value/Consideration
$5,000.00
Note: If consideration is non-cash, provide details and estimated valuation
No. of securities held after change
Nature of change
Example: on-market trade, off-market trade, exercise of options, issue of
securities under dividend reinvestment plan, participation in buy-back
3,874,290 Ordinary Fully Paid Shares
On-market trade
+ See chapter 19 for defined terms.
01/01/2011
Appendix 3Y Page 1
Appendix 3Y
Change of Director’s Interest Notice
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed
in this part.
Detail of contract
Nature of interest
Name of registered holder
(if issued securities)
Date of change
No. and class of securities to
which interest related prior to
change
Note: Details are only required for a contract in relation
to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration
Note: If consideration is non-cash, provide details and an
estimated valuation
Interest after change
Part 3 – +Closed period
Were the interests in the securities or contracts detailed No
above traded during a +closed period where prior written
clearance was required?
If so, was prior written clearance provided to allow the trade
to proceed during this period?
If prior written clearance was provided, on what date was this
provided?
+ See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Share your feedback
Discover